Brian Culley

Welcome to the first episode of The Cancer Impact Network podcast series! Our first guest is Brian Culley, CEO of Lineage Cell Therapeutics.  Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs such as dry AMD and patients with acute spinal cord injuries. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. Brian Culley discusses Lineage’s clinical programs in dry-AMD, spinal cord injury and cancer, markets with billion dollar opportunities. He also shares how Lineage is utilizing a novel hybrid approach of regenerative medicine in combination with allogeneic, or non-patient specific immune-mediated targeting of cancer cells. Their Phase 1 clinical trial for patients with non-small cell lung cancer (NSCLC) is currently underway and is being conducted by Cancer Research UK. Brian Culley, M.Sc, MBA  CEO, Lineage Cell Therapeutics  In discussion with: Himabindu Gaddipati, MD EMTM CEO, Lumiseek Inc.

Welcome to the first episode of The Cancer Impact Network podcast series! Our first guest is Brian Culley, CEO of Lineage Cell Therapeutics.  Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs such as dry AMD and patients with acute spinal cord injuries. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. Brian Culley discusses Lineage’s clinical programs in dry-AMD, spinal cord injury and cancer, markets with billion dollar opportunities. He also shares how Lineage is utilizing a novel hybrid approach of regenerative medicine in combination with allogeneic, or non-patient specific immune-mediated targeting of cancer cells. Their Phase 1 clinical trial for patients with non-small cell lung cancer (NSCLC) is currently underway and is being conducted by Cancer Research UK. Brian Culley, <a href="http://M.Sc" rel="nofollow" target="_blank">M.Sc</a>, MBA  CEO, Lineage Cell Therapeutics  In discussion with: Himabindu Gaddipati, MD EMTM CEO, Lumiseek Inc.

In Discussion with Brian Culley, CEO of Lineage Cell Therapeutics

This podcast was started as a way to highlight industry professionals who are transforming the oncology space in some manner.

Lumiseek: The Cancer Impact Network Podcast

The best podcast episodes on romantic relationships. Episodes talk about the 5 love languages, intimacy, and the taboo topics of sexual desires and infidelity. This topic is a deep dive into the science and complexities that face us in our relationships with others. Add episodes you're interested into your queue below!

Best Episodes on Relationships & Love

The best podcast episodes on non-current politics. Covering topics such as universal basic income, democracy, poverty & justice and more. For anyone interested in learning more about politics that affect that world, not just now, but in the longer term. Add episodes you're interested into your queue below!